Revvity, Inc. (LON:0KHE)
London flag London · Delayed Price · Currency is GBP · Price in USD
94.56
-7.83 (-7.64%)
Feb 12, 2026, 4:50 PM GMT

Revvity Revenue

In the year 2025, Revvity had annual revenue of $2.86B USD with 3.67% growth. Revvity had revenue of $772.06M in the quarter ending December 28, 2025, with 5.85% growth.

Revenue
$2.86B
Revenue Growth
+3.67%
P/S Ratio
3.97
Revenue / Employee
$259.64K
Employees
11,000
Market Cap
8.40B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 20252.86B101.03M3.67%
Dec 29, 20242.76B4.46M0.16%
Dec 31, 20232.75B-561.25M-16.95%
Jan 1, 20233.31B-515.99M-13.48%
Jan 2, 20223.83B1.16B43.73%
Jan 3, 20212.66B-220.44M-7.64%
Dec 29, 20192.88B105.68M3.80%
Dec 30, 20182.78B521.01M23.08%
Dec 31, 20172.26B141.47M6.69%
Jan 1, 20172.12B10.69M0.51%
Jan 3, 20162.10B34.94M1.69%
Dec 28, 20142.07B-87.71M-4.07%
Dec 29, 20132.16B52.40M2.49%
Dec 30, 20122.11B186.68M9.73%
Jan 1, 20121.92B216.74M12.74%
Jan 2, 20111.70B151.00M9.74%
Jan 3, 20101.55B-108.90M-6.56%
Dec 28, 20081.66B-69.21M-4.00%
Dec 30, 20071.73B251.19M17.00%
Dec 31, 20061.48B3.85M0.26%
Jan 1, 20061.47B44.74M3.13%
Jan 2, 20051.43B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.24B
GSK plc32.67B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
Convatec Group1.72B
CVS Group673.20M
Genus672.80M
Revenue Rankings